Clinical trial Papaldo
A phase II randomized study to verify the Papaldo's hypothesis : the effectiveness of a reduced dosing of G-CSF in chemotherapy-treated patients with a low to moderate risk of febrile neutropenia
Cancers | |
---|---|
Organ | Breast |
Trial status | Trial closed for recruitment |
Investigator | |
Trial type |
Interventional without experimental drug
|
Phase | Trial phase 2 |
Academic trial | Oui |
Sponsor | Institut Jules Bordet |
BECT Identifier | B079201110979 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT01658956 |
Inclusion criteria | Adjuvant or neoadjuvant |
Last update |